Has anyone done RNA-Seq with reads that failed chastity test? When we sequence, we get a export file and fastq file back from Illumina. The export file usually has a few million reads extra that failed chastity and never made it into the fastq file. In one of our samples, 75% of the reads failed chastity. I assume it is safe to use these reads during mapping? If they are truly bad reads, they shouldn't map. Or does anyone disagree???
Unconfigured Ad
Collapse
X
-
Tags: None
-
First things first, if you I had 75% failed reads I would call that a failed run and request a re-run from your service provider.Originally posted by blindtiger454 View PostHas anyone done RNA-Seq with reads that failed chastity test? When we sequence, we get a export file and fastq file back from Illumina. The export file usually has a few million reads extra that failed chastity and never made it into the fastq file. In one of our samples, 75% of the reads failed chastity. I assume it is safe to use these reads during mapping? If they are truly bad reads, they shouldn't map. Or does anyone disagree???
Can you use the failed reads? Sure, you can but is it wise to do so. What is your experiment? If you are strictly doing expression analysis, that is counting fragments aligned to transcription units then you could probably get away with it. On the other hand if you are interested in identifying variations (e.g. SNPs) then I would not use failed reads. They would produce too many false positives. In fact if you are using your sequence data for variant discovery you should go beyond the Illumina chastity filters, cleaning up the reads even further.
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 10-22-2026, 11:13 AM
|
0 responses
22 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 11:13 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 10:48 AM
|
0 responses
18 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 10:48 AM
|
||
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
36 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
42 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
Comment